Journal: Communications Biology
Article Title: Macrophage-derived IL-1β directs fibroblast progenitor cell fate via metabolic reprogramming in wound healing
doi: 10.1038/s42003-025-08754-w
Figure Lengend Snippet: A A dot plot demonstrates the enriched expression of Il1r1 in Cluster 22 relative to other fibroblast subsets. B CellChat analysis of ligand-receptor interactions within the IL-1 signaling network between Cluster 2 and fibroblast subsets, showing the most potent IL-1 signaling from C2 (macrophages) to C22 ( Il1rl1 + fibroblasts) in the oral mucosa. The color gradient reflects the interaction intensity. C Flow cytometric analysis confirms increased NFκB/PP65 expression in the fibroblasts of the oral mucosa with the same level of exogenous IL-1B, with * p < 0.001 and ‘ns’ denoting no significant difference ( n = 3). Error bars represent SEM. D Measurement of oxygen consumption rate (OCR) in oral mucosa and skin fibroblasts treated with exogenous IL-1β, respectively. Gray lines indicated the time points of adding oligomycin, carbonyl cyanite-4 (trifluoromethoxy) phenylhydrazone (FCCP), and Rotenone. E , F Statistical analysis of basal respiration ( E ) and ATP production ( F ), ** p < 0.01 and ‘ns’ indicating no significant difference ( n = 4). Error bars represent standard deviation (SD). G Measurement of extracellular acidification rate (ECAR) in oral mucosa and skin fibroblasts treated with exogenous IL-1β, respectively. Gray lines indicated the time points of adding glucose, oligomycin and 2-DG. H , I Statistical analysis of glycolytic capacity ( H ) and glycolysis ( I ), ** p < 0.01, ** p < 0.05, and ‘ns’ indicating no significant difference ( n = 5). Error bars represent SD. J Flow cytometric analysis confirms decreased NFκB/PP65 expression in C22 fibroblasts of the injured oral mucosa after applying the proteasome inhibitor, with * p < 0.05 and ‘ns’ denoting no significant difference ( n = 6). Error bars represent SEM. K Flow cytometric analysis confirms decreased NDUFA4 expression in C22 fibroblasts of the injured oral mucosa after applying the proteasome inhibitor, with * p < 0.05 and ‘ns’ denoting no significant difference ( n = 6). Error bars represent SEM. L Flow cytometric analysis confirms decreased PDGFRA level in the injured oral mucosa after applying the proteasome inhibitor, with *** p < 0.001 and ‘ns’ denoting no significant difference ( n = 6). Error bars represent SEM. M Histological analysis of oral mucosa after treatment with MG132 using H&E staining. Bar = 300 μm.
Article Snippet: Antibodies were used for flowcytometry: PDGFRA-PE (135905, Biolegend, 1:100), Ki67- Alexa Fluor 700 (56-5698-82, Invitrogen, 1:100), CD45-FITC (103108, Biolegend, 0.5:100), IL-1β-PerCP 710 (46-7114-82, Invitrogen, 1:100), IL1RL1-Alexa Fluor 700 (FAB10041N, R&D systems, 1:100), PP65-APC (MA5-37167, Invitrogen, 1:100), PGK1 (Polyclonal Rabbit IgG, PA5-28612, Invitrogen, 0.5:100), NDUFA4 (Polyclonal Rabbit IgG, PA5-51021, Invitrogen, 1:100), FITC-conjugated Goat Anti-Rabbit IgG (SA00003-2, Proteintech, 1:300).
Techniques: Expressing, Standard Deviation, Staining